Año: 2023
Journal Impact Factor (JIF): 3.90
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| INFECTIOUS DISEASES | SCIE | 32/132 | Q1 | T1 | D3 |
| PHARMACOLOGY & PHARMACY | SCIE | 85/354 | Q1 | T1 | D3 |
| MICROBIOLOGY | SCIE | 57/161 | Q2 | T2 | D4 |
Año: 2023
Journal Citation Indicator (JCI): 1,110
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| INFECTIOUS DISEASES | 25/132 | Q1 | T1 | D2 | 81,44 |
| MICROBIOLOGY | 32/161 | Q1 | T1 | D2 | 80,44 |
| PHARMACOLOGY & PHARMACY | 67/354 | Q1 | T1 | D2 | 81,22 |
Año:
2023
CiteScore:
9,200
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Pharmacology (medical) | 26/272 | Q1 | T1 | D1 |
| Infectious Diseases | 52/344 | Q1 | T1 | D2 |
| Microbiology (medical) | 27/140 | Q1 | T1 | D2 |
| Pharmacology | 43/313 | Q1 | T1 | D2 |
SJR año:
2023
Factor de Impacto:
1,271
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Infectious Diseases | 49/340 | Q1 | T1 | D2 |
| Microbiology (medical) | 23/136 | Q1 | T1 | D2 |
| Pharmacology | 47/323 | Q1 | T1 | D2 |
| Pharmacology (medical) | 33/276 | Q1 | T1 | D2 |
| Agencia | Código de Proyecto |
|---|---|
| CIBERINFEC | 21/13/00012; 21/13/00048; 21/13/00084 |
| COMBACTE-NET | 115523; 115620 |
| European Development Regional | - |
| Joint Project of Chongqing Science and Technology Bureau and Chongqing Health Commission of China | 2020FYYX005 |
| Plan Nacional de I + D + I, Instituto de Salud Carlos III, Subdireccion General de Redes y Centros de Investigacion Cooperativa, Ministerio de Ciencia, Innovacion y Universidades, Spanish Network for Research in Infectious Diseases | REIPI RD16/0016/0001; RD16/0016/0008; RD16/0016/0011 |
| Swiss National Science Foundation | P4P4PM_194449 |
| # | Autor | Afiliación |
|---|---|---|
| 1 | Zhou, HY | University of Geneva; Chongqing Medical University (Switzerland) |
| 2 | Institut National de la Sante et de la Recherche Medicale (Inserm); University of Geneva (Switzerland) | |
| 3 | Pérez-Galera, S | Hospital Universitario Virgen Macarena; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS) (Spain) |
| 4 | Bravo-Ferrer, J | Hospital Universitario Virgen Macarena; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS) (Spain) |
| 5 | Gutiérrez-Gutiérrez, B | Hospital Universitario Virgen Macarena; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Instituto de Salud Carlos III (Spain) |
| 6 | Paniagua-García, M | CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Instituto de Salud Carlos III; Virgen del Rocio University Hospital (Spain) |
| 7 | Jan, FF | Ulm University (Germany) |
| 8 | Sauser, J | University of Geneva (Switzerland) |
| 9 | Kostyanev, T | University of Antwerp; Technical University of Denmark National Food Institute (Denmark) |
| 10 | Canton, R | Instituto de Salud Carlos III; Hospital Universitario Ramón y Cajal; Inst Ramon y Cajal Invest Sanitaria (Spain) |
| 11 | Tan, LK | GlaxoSmithKline (England) |
| 12 | Basoulis, D | Laiko General Hospital (Greece) |
| 13 | Pintado, V | Instituto de Salud Carlos III; Hospital Universitario Ramón y Cajal; Inst Ramon y Cajal Invest Sanitaria (Spain) |
| 14 | Roilides, E | Aristotle University of Thessaloniki School of Medicine (Greece) |
| 15 | Dragovac, G | University of Novi Sad; University of Novi Sad Medical Faculty (Serbia) |
| 16 | Torre-Cisneros, J | Universidad de Cordoba; Instituto de Salud Carlos III (Spain) |
| 17 | Mediç, D | University of Novi Sad; University of Novi Sad Medical Faculty (Serbia) |
| 18 | Akova, M | Hacettepe University Faculty of Medicine (Turkiye) |
| 19 | Goossens, H | University of Antwerp (Belgium) |
| 20 | Bonten, M | Julius Centrum voor Gezondheidswetenschappen en Eerstelijns Geneeskunde; Utrecht University Medical Center (Netherlands) |
| 21 | Harbarth, S | University of Geneva (Switzerland) |
| 22 | Rodriguez-Baño, J | Hospital Universitario Virgen Macarena; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Instituto de Salud Carlos III (Spain) |
| 23 | De Kraker, MEA | University of Geneva (Switzerland) |
| # | Autoría grupal | Afiliación |
| 24 | COMBACTE-EURECA Project Team | Sin datos () |
